{"id":1068295,"date":"2022-10-03T01:51:14","date_gmt":"2022-10-03T05:51:14","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/gaston-picchio-phd-chief-development-officer-to-depart-arbutus-at-year-end\/"},"modified":"2024-08-18T11:45:29","modified_gmt":"2024-08-18T15:45:29","slug":"gaston-picchio-phd-chief-development-officer-to-depart-arbutus-at-year-end","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/gaston-picchio-phd-chief-development-officer-to-depart-arbutus-at-year-end.php","title":{"rendered":"Gaston Picchio, PhD, Chief Development Officer, to Depart Arbutus at Year End"},"content":{"rendered":"<p><![CDATA[WARMINSTER, Pa., Sept.  30, 2022  (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that Gaston Picchio, PhD, Chief Development Officer, will be leaving the Company for personal reasons. Dr. Picchio will continue to serve as CDO until his departure on December 31, 2022. The Company has initiated a search for Dr. Picchio\u2019s replacement.]]><\/p>\n<p>Read more from the original source:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/09\/30\/2526044\/0\/en\/Gaston-Picchio-PhD-Chief-Development-Officer-to-Depart-Arbutus-at-Year-End.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Gaston Picchio, PhD, Chief Development Officer, to Depart Arbutus at Year End\">Gaston Picchio, PhD, Chief Development Officer, to Depart Arbutus at Year End<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read more from the original source: Gaston Picchio, PhD, Chief Development Officer, to Depart Arbutus at Year End <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/gaston-picchio-phd-chief-development-officer-to-depart-arbutus-at-year-end.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068295","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068295"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068295"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068295\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}